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The relationship between wealth and health outcomes is one of the 
most important topics in the field of health economics. If it could be 
demonstrably shown that wealthier people live much healthier lives, 
then economic growth would certainly need to have a bigger role in 
health care reform. However, the literature on this topic is intensely 
mixed, and it has proven to be one of the most hotly debated topics 
the field, with some, such as Arthur van Soest, concluding that the 
“health-wealth gradient” is not an important factor to consider in 
health care reform, but others, such as Hannes Schwandt, 
concluding that wealth is an important factor to consider.
BACKGROUND
DAT
AData was assembled from the following sources:
• America’s Health Rankings, a product of UHF. This rating system 
measures health outcomes such as cancer deaths, diabetes and 
infant mortality to assign each state an index value of health 
outcomes from -1 to +1. 
• BEA estimates of real GDP per capita in the years 2003 and 2013. 
Both years’ estimates use a base year of 1990.
• Region-based effects were controlled using regional groups as 
defined by the BEA.
Some of the more interesting EDA results are shown in Fig. 1. In 
terms of GDP, there is a large gap between the top seven states and 
the rest. The linear prediction shows an apparent positive relationship 
between wealth and health outcomes, but this is before any real 
model-building takes place.
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The goal of this model is to estimate the effect of real GDP on health 
outcomes. With observations from the years 2003 and 2013, this 
dataset made a great candidate for instrumental variable analysis. 
Thus, the main methods used in model-building were instrumental 
variable analysis and two-stage least squares regression.
In the first stage, I use GDP in the year 2003 as an instrument upon 
GDP in the year 2013. GDP in 2003 meets the requirements of a 
strong instrument: it is highly correlated with GDP in 2013, but 
uncorrelated with a state’s health index in 2013 (see Fig. 2). Using an 
instrument gives a much more accurate estimate, reducing the 
possibility of omitted variable bias in the model.
In the second stage, I use the instrumented variable to estimate the 
effect of GDP upon health outcomes, producing the regression output 
seen in Fig. 3.
RESULT
S
METHODS
IMPROVEMENTS / 
FURTHER RESEARCH
CONCLUSIONS
According to this model, there is little to no causal effect of a state’s 
GDP on health outcomes, with the results being insignificant and 
inconclusive in almost every measurable way. In Fig. 3, the z-statistic 
of 0.99 and the corresponding p-value show that the coefficient of the 
GDP variable is not statistically significant at the 5% or even 10% 
level. In addition, the 95% confidence interval shows that it is uncertain 
whether the effect of GDP on health outcomes is positive or negative – 
such an uncertain result means that this model shows no evidence of 
a causal link between a state’s GDP and its health outcomes.
These findings support the conclusion, as argued by Arthur van Soest 
and others, that the “health-wealth gradient,” while an interesting idea, 
doesn’t adequately describe how health outcomes transpire in the 
United States. Factors besides individual wealth must be prioritized in 
the modeling of health outcomes.
• Continuing to develop and improve the data set will make 
for more robust results.
• Longitudinal analysis could be used as an alternative to 
instrumental variable regression, but this would require a 
change in the way observations are grouped.
• An exploration into the policy implications of these 
findings will greatly enhance the research.
